We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Aortitis after switching short-acting granulocyte colony-stimulating factors in a lymphoma patient with HLA-B52

    Aortitis is a rare adverse event of granulocyte colony-stimulating factor (G-CSF) treatment. Several previous studies have described recurrent...

    Misato Tane, Hideki Kosako, ... Takashi Sonoki in International Journal of Hematology
    Article 23 March 2024
  2. Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer

    Purpose

    Clinical practice guidelines recommend the use of all approved granulocyte colony-stimulating factors (G-CSFs), including filgrastim and...

    Matti S. Aapro, Stephen Chaplin, ... Robert Terkola in Supportive Care in Cancer
    Article Open access 20 September 2023
Did you find what you were looking for? Share feedback.